The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Altered trafficking and stability of polycystins underlie polycystic kidney disease
Open accessAbstract
The most severe form of autosomal dominant polycystic kidney disease occurs in patients with mutations in the gene (PKD1) encoding polycystin-1 (PC1). PC1 is a complex polytopic membrane protein expressed in cilia that undergoes autoproteolytic cleavage at a G protein-coupled receptor proteolytic site (GPS). A quarter of PKD1 mutations are missense variants, though it is not clear how these mutations promote disease. Here, we established a cell-based system to evaluate these mutations and determined that GPS cleavage is required for PC1 trafficking to cilia. A common feature among a subset of pathogenic missense mutations is a resulting failure of PC1 to traffic to cilia regardless of GPS cleavage. The application of our system also identified a missense mutation in the gene encoding polycystin-2 (PC2) that prevented this protein from properly trafficking to cilia. Using a Pkd1-BAC recombineering approach, we developed murine models to study the effects of these mutations and confirmed that only the cleaved form of PC1 exits the ER and can rescue the embryonically lethal Pkd1-null mutation. Additionally, steady-state expression levels of the intramembranous COOH-terminal fragment of cleaved PC1 required an intact interaction with PC2. The results of this study demonstrate that PC1 trafficking and expression require GPS cleavage and PC2 interaction, respectively, and provide a framework for functional assays to categorize the effects of missense mutations in polycystins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195 · cited 2×
“These findings raise the possibility that targeted personalized therapeutic strategies based on the specific nature of the mutations (69) may be applicable to ADPKD.”
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Hildebrandt, F., Benzing, T., & Katsanis, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010172 · Cited by 1,331
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935 · cited 1×
“PC1 and PC2 are expressed in the membrane overlying the primary cilium (25, 26).”
Pazour, G. J., San Agustin, J. T., Follit, J. A., Rosenbaum, J. L., & Witman, G. B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00877-1 · Cited by 531 · cited 1×
“PC1 and PC2 are expressed in the membrane overlying the primary cilium (25, 26).”
Davenport, J. R., Watts, A. J., Roper, V. C., Croyle, M. J., van Groen, T., Wyss, J. M., Nagy, T. R., Kesterson, R. A., & Yoder, B. K. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.034 · Cited by 482
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64313 · Cited by 442 · cited 3×
“Functional defects resulting from missense mutations thought to be patho genic in ADPKD include loss of GPS cleavage (73) and changes in protein folding and trafficking (47) in PC1 and loss of channel activity in PC2 (17).”
Choi, Y.-H., Suzuki, A., Hajarnis, S., Ma, Z., Chapin, H. C., Caplan, M. J., Pontoglio, M., Somlo, S., & Igarashi, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016214108 · Cited by 139
Self-citationPolycystin-1: A master regulator of intersecting cystic pathways
Fedeles, S. V., Gallagher, A.-R., & Somlo, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.004 · Cited by 130
Cited by
Autosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Cornec-Le Gall, E., Torres, V. E., & Harris, P. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050483 · Cited by 406
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
Lanktree, M. B., Haghighi, A., Guiard, E., Iliuta, I.-A., Song, X., Harris, P. C., Paterson, A. D., & Pei, Y. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050493 · Cited by 300
Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease
Cruz, N. M., Song, X., Czerniecki, S. M., Gulieva, R. E., Churchill, A. J., Kim, Y. K., Winston, K., Tran, L. M., Diaz, M. A., Fu, H., et al. (2017) · Nature Materials · doi:10.1038/nmat4994 · Cited by 291
Structure of the human PKD1-PKD2 complex
Su, Q., Hu, F., Ge, X., Lei, J., Yu, S., Wang, T., Zhou, Q., Mei, C., & Shi, Y. (2018) · Science · doi:10.1126/science.aat9819 · Cited by 284
“Mutation R3162C in PLAT or W414G in TOP abrogates proper trafficking of PKD1 or PKD2, respectively (25, 31).”
BackgroundAutosomal dominant polycystic kidney disease: the changing face of clinical management
Ong, A. C. M., Devuyst, O., Knebelmann, B., & Walz, G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60907-2 · Cited by 280
Isolated polycystic liver disease genes define effectors of polycystin-1 function
Besse, W., Dong, K., Choi, J., Punia, S., Fedeles, S. V., Choi, M., Gallagher, A.-R., Huang, E. B., Gulati, A., Knight, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90129 · Cited by 203
Self-citationLiu, X., Vien, T., Duan, J., Sheu, S.-H., DeCaen, P. G., & Clapham, D. E. (2018) · eLife · doi:10.7554/elife.33183 · Cited by 186
“In some studies, polycystin-2 is absent from primary cilia without polycystin-1 or vice versa (Gainullin et al., 2015; Kim et al., 2014), while others showed polycystin-2 traffic to cilia is independent of polycystin-1 (Cai et al., 2014; Geng et al., 2006; Hoffmeister et al., 2011).”
BackgroundTubby family proteins are adapters for ciliary trafficking of integral membrane proteins
Badgandi, H. B., Hwang, S.-H., Shimada, I. S., Loriot, E., & Mukhopadhyay, S. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201607095 · Cited by 182
Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease
Ma, M., Gallagher, A.-R., & Somlo, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028209 · Cited by 133
Self-citationLi, A., Fan, S., Xu, Y., Meng, J., Shen, X., Mao, J., Zhang, L., Zhang, X., Moeckel, G., Wu, D., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13091 · Cited by 42
Activation of polycystin-1 signaling by binding of stalk-derived peptide agonists
Pawnikar, S., Magenheimer, B. S., Joshi, K., Nevarez-Munoz, E., Haldane, A., Maser, R. L., & Miao, Y. (2024) · eLife · doi:10.7554/elife.95992 · Cited by 9
Li, W., Liang, J., Outeda, P., Turner, S., Wakimoto, B. T., & Watnick, T. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009217 · Cited by 6
Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide Agonists
(2024) · doi:10.1101/2024.01.06.574465 · Cited by 1
Metadata
- Authors
- Cai, Y., Fedeles, S. V., Dong, K., Anyatonwu, G., Onoe, T., Mitobe, M., Gao, J.-D., Okuhara, D., Tian, X., Gallagher, A.-R., Tang, Z., Xie, X., Lalioti, M. D., Lee, A.-H., Ehrlich, B. E., & Somlo, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-11-03
- Volume
- 124
- Issue
- 12
- Pages
- 5129-5144
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2078277615
- Cited by
- 158
- References
- 10
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.